Massive Bio

About Massive Bio

Massive Bio is an oncology technology company that uses AI-assisted tools to connect cancer patients with clinical trials that match their diagnosis and genomic profile. The platform coordinates with physicians, drug developers, hospitals, and genomic companies to enable trial discovery and enrollment across multiple markets. The company emphasizes patient-centric experiences, professional networks, and global trial access, including resources for patients and caregivers and collaboration with healthcare providers. Headquartered with offices in the United States and Turkey, Massive Bio operates internationally to improve access to cancer trials.